Alembic Pharmaceuticals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| APLLTD.BO | ASTRAZEN.NS | ALKEM.NS | AUROPHARMA.NS | AKUMS.BO | GRANULES.BO | |
|---|---|---|---|---|---|---|
| Market cap | 176.07B | 157.35B | 620.54B | 1.03T | 114.04B | 192.80B |
| P/E (TTM) | 20.9 | 92.8 | 28.8 | 25.8 | 31.3 | 35.3 |
| Forward P/E | 18.3 | — | 23.2 | 19.0 | 21.8 | 26.5 |
| Price/book | 3.0 | 18.0 | 4.5 | 2.7 | 3.3 | 4.8 |
| Dividend yield | 1.32% | 0.57% | 0.38% | — | 0.13% | 0.26% |
| 1-year change | −16.24% | −30.90% | −7.56% | +47.46% | +65.09% | +0.63% |
| Today | −1.26% | −1.16% | −0.51% | +4.53% | −0.76% | −0.01% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All APLLTD.BO news ›Alembic Pharmaceuticals receives USFDA approval for ophthalmic solution
Alembic Pharmaceuticals gets USFDA approval for eye drop InvestyWise Alembic Pharmaceuticals receives USFDA approval for ophthalmic solution Alembic Pharmaceuticals Limited has announced the receipt of final approval from the US Food &…
Alembic Pharmaceuticals Ltd receives USFDA Final Approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, 0.3% / 0.1%.
Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ciprofloxacin and Dexamethasone Otic Suspension USP,…
Alembic Pharmaceuticals: Gets USFDA Approval for Otic Suspension
InvestyWise delivers real-time Indian stock market news, corporate filings, regulatory disclosures, and financial analysis. Track NSE and BSE-listed companies with AI-powered insights for smarter investment decisions. Alembic…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
Most coverage from
- investywise.com2
- equitybulls.com1
- sahi.com1
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.